Senior StatisticianNovo Nordisk A/S, Søborg, DenmarkSøborg, Hovedstaden, Denmark
OC 59.1 - Concizumab prophylaxis in patients with haemophilia A or B without inhibitors: Efficacy and safety results from the primary analysis of the phase 3 explorer8 study
Tuesday, June 27, 202314:45 – 15:00 ET
